600521 华海药业
已收盘 07-18 15:00:00
资讯
新帖
简况
北向资金7月17日净卖出华海药业3.88万股 连续7日减持
自选股智能写手 · 07-18 09:30
北向资金7月17日净卖出华海药业3.88万股 连续7日减持
华海药业最新公告:富马酸喹硫平片获药品注册证书
证券之星 · 07-16 18:10
华海药业最新公告:富马酸喹硫平片获药品注册证书
华海药业: 产品取得注册证
每日经济新闻 · 07-16 17:52
华海药业: 产品取得注册证
华海药业(600521.SH):富马酸喹硫平片获药品注册证书
智通财经 · 07-16 17:48
华海药业(600521.SH):富马酸喹硫平片获药品注册证书
北向资金7月15日净卖出华海药业147.03万股 连续5日减持
自选股智能写手 · 07-16 09:30
北向资金7月15日净卖出华海药业147.03万股 连续5日减持
华海药业07月12日主力资金流入478万元 连续3日加仓
自选股智能写手 · 07-12
华海药业07月12日主力资金流入478万元 连续3日加仓
又一只医药股股价和业绩齐飞,年内涨幅近23%
中国制药网 · 07-12
又一只医药股股价和业绩齐飞,年内涨幅近23%
北向资金7月11日净卖出华海药业134.15万股 连续3日减持
自选股智能写手 · 07-12
北向资金7月11日净卖出华海药业134.15万股 连续3日减持
华海药业最新公告:子公司获药物临床试验许可
证券之星 · 07-08
华海药业最新公告:子公司获药物临床试验许可
华海药业(600521.SH):HB0046注射液临床试验获批
智通财经 · 07-08
华海药业(600521.SH):HB0046注射液临床试验获批
华海药业:子公司获药物临床试验许可
财通社 · 07-08
华海药业:子公司获药物临床试验许可
ETF最前线 | 易方达沪深300医药ETF(512010)早盘下跌1.54%,创新药主题走弱,华海药业上涨1.12%
21世纪经济报道 · 07-08
ETF最前线 | 易方达沪深300医药ETF(512010)早盘下跌1.54%,创新药主题走弱,华海药业上涨1.12%
概念掘金 | 创新药重磅政策落地!多主线投资机会显现
格隆汇 · 07-08
概念掘金 | 创新药重磅政策落地!多主线投资机会显现
北向资金7月5日净买入华海药业196.88万股 连续5日增持
自选股智能写手 · 07-08
北向资金7月5日净买入华海药业196.88万股 连续5日增持
华海药业获得发明专利授权:“一种三苯基氯甲烷的制备方法”
证券之星 · 07-08
华海药业获得发明专利授权:“一种三苯基氯甲烷的制备方法”
龙虎榜 | 机构、沪股通联手“狂买”华海药业,山东帮出逃金溢科技!
格隆汇 · 07-05
龙虎榜 | 机构、沪股通联手“狂买”华海药业,山东帮出逃金溢科技!
华海药业最新公告:奥美沙坦酯氨氯地平片获药品注册证书
证券之星 · 07-05
华海药业最新公告:奥美沙坦酯氨氯地平片获药品注册证书
华海药业(600521.SH):奥美沙坦酯氨氯地平片获得药品注册证书
港股那点事 · 07-05
华海药业(600521.SH):奥美沙坦酯氨氯地平片获得药品注册证书
7月5日华海药业涨10.02%,安信医药健康股票A基金重仓该股
证券之星 · 07-05
7月5日华海药业涨10.02%,安信医药健康股票A基金重仓该股
7月5日华海药业涨停分析:创新药,化学原料药,新冠药物概念热股
证券之星 · 07-05
7月5日华海药业涨停分析:创新药,化学原料药,新冠药物概念热股
加载更多
公司概况
公司名称:
浙江华海药业股份有限公司
所属行业:
医药制造业
上市日期:
2003-03-04
主营业务:
浙江华海药业股份有限公司主营业务为多剂型的仿制药、生物药、创新药及特色原料药的研发、生产和销售。公司的主要产品有心血管类、精神障碍类、神经系统类、抗感染类等为主导的产品系列。2023年4月,公司荣获“全国五一劳动奖状”和“浙江省五一劳动奖状”,同月,公司被浙江省药品检查中心认定为浙江省职业检查“尖兵领航”工程实训基地;2023年6月,公司入选米内网颁发的2022年度中国化药企业百强等。
发行价格:
15.55
{"stockData":{"symbol":"600521","market":"SH","secType":"STK","nameCN":"华海药业","latestPrice":17.68,"timestamp":1721286000000,"preClose":17.54,"halted":0,"volume":10794942,"delay":0,"floatShares":1467000000,"shares":1467000000,"eps":0.633,"marketStatus":"已收盘","marketStatusCode":5,"change":0.14,"latestTime":"07-18 15:00:00","open":17.62,"high":17.68,"low":17.29,"amount":189000000,"amplitude":0.0222,"askPrice":17.68,"askSize":74,"bidPrice":17.67,"bidSize":27,"shortable":0,"etf":0,"ttmEps":0.633,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721352600000},"adr":0,"adjPreClose":17.54,"symbolType":"stock","openAndCloseTimeList":[[1721266200000,1721273400000],[1721278800000,1721286000000]],"highLimit":19.29,"lowLimit":15.79,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1466755454,"pbRate":3.21,"roa":"--","roe":"3.31%","epsLYR":0.57,"committee":-0.659896,"marketValue":25932000000,"floatMarketCap":25932000000,"peRate":27.930489,"changeRate":0.008,"turnoverRate":0.0074,"status":0},"requestUrl":"/m/hq/s/600521","defaultTab":"news","newsList":[{"id":"2452454361","title":"北向资金7月17日净卖出华海药业3.88万股 连续7日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2452454361","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452454361?lang=zh_cn&edition=full","pubTime":"2024-07-18 09:30","pubTimestamp":1721266213,"startTime":"0","endTime":"0","summary":"7月17日,北向资金减持华海药业3.88万股连续7日减持。截止当日收盘,沪股通共持有华海药业5899.68万股,占流通股4.02%。沪股通减持金额前五个股分别为紫金矿业、长江电力、工业富联、洛阳钼业、中国铝业。华海药业近5个交易日下跌1.41%,沪股通累计减持591.65万股;近20个交易日上涨1.68%,沪股通累计增持23.72万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180931319f60e361&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407180931319f60e361&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0201","BK0185","BK0239","600521","BK0070","BK0012","BK0028"],"gpt_icon":0},{"id":"2451961254","title":"华海药业最新公告:富马酸喹硫平片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2451961254","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451961254?lang=zh_cn&edition=full","pubTime":"2024-07-16 18:10","pubTimestamp":1721124635,"startTime":"0","endTime":"0","summary":"华海药业公告,公司于近日收到国家药品监督管理局核准签发的富马酸喹硫平片的《药品注册证书》。富马酸喹硫平片用于治疗精神分裂症和双相情感障碍的躁狂发作。根据米内网数据预测,富马酸喹硫平片2023年国内市场销售金额约人民币11.3亿元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600036597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600521","BK0188","BK0185","BK0012","BK0070","BK0239","BK0201"],"gpt_icon":0},{"id":"2451961239","title":"华海药业: 产品取得注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2451961239","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451961239?lang=zh_cn&edition=full","pubTime":"2024-07-16 17:52","pubTimestamp":1721123561,"startTime":"0","endTime":"0","summary":"每经AI快讯,华海药业(SH 600521,收盘价:17.46元)7月16日晚间发布公告称,浙江华海药业股份有限公司于近日收到国家药品监督管理局核准签发的富马酸喹硫平片的《药品注册证书》。产品名称为“富马酸喹硫平片”。截至发稿,华海药业市值为256亿元。道达号(daoda1997)“个股趋势”提醒:1. 华海药业近30日内北向资金持股量增加407.25万股,占流通股比例增加0.28%;2. 近30日内无机构对华海药业进行调研。每经头条(nbdtoutiao)——一周内多所“双一流”高校公示拟撤销部分本科专业点,为何近年撤销数量呈上升趋势?需留意这些曾热门的学科门类……(记者 曾健辉)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161753059f553cf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407161753059f553cf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","BK0188","BK0185","600521","BK0028","BK0201","BK0012","BK0070"],"gpt_icon":0},{"id":"2451660369","title":"华海药业(600521.SH):富马酸喹硫平片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2451660369","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451660369?lang=zh_cn&edition=full","pubTime":"2024-07-16 17:48","pubTimestamp":1721123296,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华海药业(600521.SH)发布公告,公司于近日收到国家药品监督管理局核准签发的富马酸喹硫平片的《药品注册证书》,富马酸喹硫平片用于治疗精神分裂症和双相情感障碍的躁狂发作。富马酸喹硫平片获得国家药监局的《药品注册证书》,进一步丰富了公司的产品线,有助于提升公司产品的市场竞争力。根据国家相关政策,公司富马酸喹硫平片按化学药品4类批准生产可视同通过一致性评价,医疗机构将会优先采购并在临床中优先选用,对公司的经营业绩产生积极的影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1151579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0185","BK0070","BK0188","600521","BK0012","BK0201","BK0239","BK0028"],"gpt_icon":0},{"id":"2451981563","title":"北向资金7月15日净卖出华海药业147.03万股 连续5日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2451981563","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451981563?lang=zh_cn&edition=full","pubTime":"2024-07-16 09:30","pubTimestamp":1721093413,"startTime":"0","endTime":"0","summary":"7月15日,北向资金减持华海药业147.03万股连续5日减持。截止当日收盘,沪股通共持有华海药业6048.14万股,占流通股4.12%。沪股通减持金额前五个股分别为工商银行、江淮汽车、北汽蓝谷、山西汾酒、德业股份。华海药业近5个交易日下跌2.79%,沪股通累计减持698.37万股;近20个交易日上涨0.40%,沪股通累计增持301.39万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407160931139f52ae75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407160931139f52ae75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600521","BK0012","BK0070","BK0028","BK0185","BK0239","BK0188","BK0201"],"gpt_icon":0},{"id":"2450374095","title":"华海药业07月12日主力资金流入478万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2450374095","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450374095?lang=zh_cn&edition=full","pubTime":"2024-07-12 15:17","pubTimestamp":1720768653,"startTime":"0","endTime":"0","summary":"07月12日, 华海药业股价跌0.06%,报收17.79元,成交金额2.44亿元,换手率0.94%,振幅1.52%,量比0.46。华海药业今日主力资金净流入478万元,连续3日净流入,上一交易日主力净流入2053万元,今日环比减少76.72%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为37.50%,平均涨幅为0.84%。该股近5个交易日上涨1.13%,主力资金累计净流出6495万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出6460万元,其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121520419f3a1093&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121520419f3a1093&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0185","600521","BK0028","BK0070","BK0239","BK0201","BK0188","BK0012"],"gpt_icon":0},{"id":"2450759223","title":"又一只医药股股价和业绩齐飞,年内涨幅近23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450759223","media":"中国制药网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450759223?lang=zh_cn&edition=full","pubTime":"2024-07-12 14:06","pubTimestamp":1720764369,"startTime":"0","endTime":"0","summary":"7月4日晚间, 华海药业 发布公告称,预计2024年上半年归母净利润7.28亿元至7.85亿元,同比增长28%-38%。受上半年业绩预喜的影响,华海药业股价次日涨停。截至7月10日收盘,该股年内涨幅已经近23%,实现了股价和业绩齐飞。除了华海药业以外,今年以来还有多家药企实现股价和业绩齐飞的局面,包括 川宁生物 、 诺泰生物 、 佐力药业 、 海 思科 等。截至7月10日收盘,川宁生物股价年内涨幅38.69%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121410419f39b5cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121410419f39b5cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0201","BK0185","BK0239","600521","159938","BK0070","BK0012","BK0028"],"gpt_icon":0},{"id":"2450448633","title":"北向资金7月11日净卖出华海药业134.15万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2450448633","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450448633?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:30","pubTimestamp":1720747814,"startTime":"0","endTime":"0","summary":"7月11日,北向资金减持华海药业134.15万股连续3日减持。截止当日收盘,沪股通共持有华海药业6357.18万股,占流通股4.33%。华海药业近5个交易日上涨10.08%,沪股通累计减持54.60万股;近20个交易日上涨2.89%,沪股通累计增持735.12万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071209313195a9f0f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071209313195a9f0f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0185","BK0070","BK0188","600521","BK0012","BK0201","BK0239","BK0028"],"gpt_icon":0},{"id":"2449729076","title":"华海药业最新公告:子公司获药物临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2449729076","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449729076?lang=zh_cn&edition=full","pubTime":"2024-07-08 17:10","pubTimestamp":1720429829,"startTime":"0","endTime":"0","summary":"华海药业公告,子公司华奥泰和华博生物收到国家药监局核准签发的HB0046注射液的药物临床试验批准通知书,适应症为晚期实体瘤。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800023885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600521","BK0012","BK1576","BK1583","BK0070","BK0028","BK0185","BK1141","03347","BK0239","BK0188","BK0201"],"gpt_icon":0},{"id":"2449726149","title":"华海药业(600521.SH):HB0046注射液临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2449726149","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449726149?lang=zh_cn&edition=full","pubTime":"2024-07-08 16:44","pubTimestamp":1720428287,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华海药业(600521.SH)发布公告,公司的下属子公司上海华奥泰生物药业股份有限公司(简称“华奥泰”)及华博生物医药技术(上海)有限公司(简称“华博生物”)收到国家药品监督管理局核准签发的HB0046注射液的《药物临床试验批准通知书》。据悉,HB0046是基于华奥泰杂交瘤和纳米抗体筛选平台自主开发的一款双特异性抗体,由抗CD39的VHH(重链可变区)片段和抗CD73的单抗连接而成。该双抗具备与CD39和CD73高亲和力,并能有效抑制膜型和可溶型CD39和CD73的酶活,在CD39和CD73的酶活抑制以及ATP(三磷酸腺苷)介导的T细胞增殖抑制方面展现出显著的协同效应。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1146929.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600521","BK0012","BK1576","BK1583","BK0070","BK0028","BK0185","BK1141","03347","BK0239","BK0188","BK0201"],"gpt_icon":0},{"id":"2449263037","title":"华海药业:子公司获药物临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2449263037","media":"财通社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449263037?lang=zh_cn&edition=full","pubTime":"2024-07-08 16:41","pubTimestamp":1720428060,"startTime":"0","endTime":"0","summary":"华海药业公告,子公司华奥泰和华博生物收到国家药监局核准签发的HB0046注射液的药物临床试验批准通知书,适应症为晚期实体瘤。截至目前,公司在HB0046项目上已投入研发费用约4204万元。HB0046是全球首个进入临床阶段的CD39&CD73双特异性抗体,展现出显著的抗肿瘤效果和良好的安全性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708164216958f43d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708164216958f43d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600521","BK0028","BK0012","BK0185","BK0201","BK0188","BK0239","BK0070"],"gpt_icon":0},{"id":"2449272717","title":"ETF最前线 | 易方达沪深300医药ETF(512010)早盘下跌1.54%,创新药主题走弱,华海药业上涨1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449272717","media":"21世纪经济报道","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449272717?lang=zh_cn&edition=full","pubTime":"2024-07-08 12:22","pubTimestamp":1720412520,"startTime":"0","endTime":"0","summary":"南方财经7月8日电,南财金融终端显示,今日创新药主题走弱,截至午间收盘 下跌1.4%。持有创新药主题股票的易方达沪深300医药ETF早盘下跌1.54%,最新价报0.32元。截至上个交易日,该基金近五个交易日净值下跌0.52%,近一个月净值下跌9.0%。该基金自成立以来净值增长率为29.84%,管理人为易方达基金管理有限公司,基金经理为余海燕。截至午间收盘,创新药主题涨跌幅最高的五只股票为:华海药业、艾力斯、科伦药业、君实生物与毕得医药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708122334958df1dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708122334958df1dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["399300","600521","BK0188","159919","159929","159992","000001.SH","BK0070","BK0012","BK0239","BK0028","512010","BK0185","BK0201"],"gpt_icon":0},{"id":"2449471187","title":"概念掘金 | 创新药重磅政策落地!多主线投资机会显现","url":"https://stock-news.laohu8.com/highlight/detail?id=2449471187","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449471187?lang=zh_cn&edition=full","pubTime":"2024-07-08 11:03","pubTimestamp":1720407822,"startTime":"0","endTime":"0","summary":"前景向好","market":"hk","thumbnail":"https://img3.gelonghui.com/b2683-2091f5cb-365b-4f9a-b8c2-21c160148bbb.jpg?guru_height=852&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/b2683-2091f5cb-365b-4f9a-b8c2-21c160148bbb.jpg?guru_height=852&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/836139","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0070","BK0183","BK0201","600867","LU1328615791.USD","688506","BK0028","LU0405327494.USD","BK0185","BK0196","BK1161","BK0060","600276","LU1064130708.USD","BK0239","BK0262","LU0405327148.USD","BK0012","688488","06978","600521","BK1574","LU2148510915.USD","688180","BK0188","LU1064131003.USD"],"gpt_icon":0},{"id":"2449908617","title":"北向资金7月5日净买入华海药业196.88万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2449908617","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449908617?lang=zh_cn&edition=full","pubTime":"2024-07-08 09:30","pubTimestamp":1720402213,"startTime":"0","endTime":"0","summary":"7月5日, 北向资金增持华海药业196.88万股,连续5日增持。截止当日收盘,沪股通共持有华海药业6608.66万股,占流通股4.50%。沪股通增持金额前五个股分别为国投电力、中金黄金、中国核电、川投能源、中国石油。华海药业近5个交易日上涨4.34%,沪股通累计增持516.16万股;近20个交易日上涨1.66%,沪股通累计增持990.60万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407080931169f1b5d2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407080931169f1b5d2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","600521","BK0070","BK0028","BK0201","BK0239","BK0188","BK0185"],"gpt_icon":0},{"id":"2449623307","title":"华海药业获得发明专利授权:“一种三苯基氯甲烷的制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2449623307","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449623307?lang=zh_cn&edition=full","pubTime":"2024-07-08 02:10","pubTimestamp":1720375830,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示华海药业新获得一项发明专利授权,专利名为“一种三苯基氯甲烷的制备方法”,专利申请号为CN202080031514.7,授权日为2024年7月5日。今年以来华海药业新获得专利授权18个,较去年同期减少了73.13%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800000134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600521","BK0239","BK0185","BK0028","BK0070","BK0188","BK0201","BK0012"],"gpt_icon":0},{"id":"2449250543","title":"龙虎榜 | 机构、沪股通联手“狂买”华海药业,山东帮出逃金溢科技!","url":"https://stock-news.laohu8.com/highlight/detail?id=2449250543","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449250543?lang=zh_cn&edition=full","pubTime":"2024-07-05 18:31","pubTimestamp":1720175479,"startTime":"0","endTime":"0","summary":"今日龙虎榜净买入额前三为金溢科技、任子行、沙钢股份","market":"us","thumbnail":"https://img3.gelonghui.com/94236-8c1d2d9e-19e8-4601-8d29-1ee088e481cb.jpg?guru_height=852&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/94236-8c1d2d9e-19e8-4601-8d29-1ee088e481cb.jpg?guru_height=852&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/833848","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["600521","300391","BK0077","002632","601028","BK0214","BK0043","BK0239","BK0012","BK0070","BK0185","002869","300546","BK0091","BK0224","BK0155","BK0201","BK0132","BK0100","BK0212","BK0086","BK0068","BK0250","BK0229","BK0188","002075","BK0162","BK0028"],"gpt_icon":0},{"id":"2449855254","title":"华海药业最新公告:奥美沙坦酯氨氯地平片获药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2449855254","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449855254?lang=zh_cn&edition=full","pubTime":"2024-07-05 17:30","pubTimestamp":1720171817,"startTime":"0","endTime":"0","summary":"华海药业公告,公司近日收到国家药监局核准签发的奥美沙坦酯氨氯地平片的《药品注册证书》。奥美沙坦酯氨氯地平片用于治疗原发性高血压。根据米内网数据预测,奥美沙坦酯氨氯地平片2023年国内市场销售金额约人民币4.87亿元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500035296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0185","BK0012","BK0201","600521","BK0070","BK0239"],"gpt_icon":0},{"id":"2449658251","title":"华海药业(600521.SH):奥美沙坦酯氨氯地平片获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2449658251","media":"港股那点事","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449658251?lang=zh_cn&edition=full","pubTime":"2024-07-05 17:22","pubTimestamp":1720171320,"startTime":"0","endTime":"0","summary":"格隆汇7月5日丨华海药业(600521.SH)公布,公司于近日收到国家药品监督管理局核准签发的奥美沙坦酯氨氯地平片的《药品注册证书》,奥美沙坦酯氨氯地平片用于治疗原发性高血压。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-07-05/doc-inccanui4158211.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-07-05/doc-inccanui4158211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0201","BK0188","BK0028","BK0070","BK0239","BK0185","BK0012","600521"],"gpt_icon":0},{"id":"2449253275","title":"7月5日华海药业涨10.02%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449253275","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449253275?lang=zh_cn&edition=full","pubTime":"2024-07-05 16:13","pubTimestamp":1720167232,"startTime":"0","endTime":"0","summary":"证券之星消息,7月5日华海药业涨10.02%,收盘报17.79元,换手率2.76%,成交量40.5万手,成交额7.05亿元。重仓华海药业的公募基金请见下表:该股最近90天内共有3家机构给出评级,买入评级3家;过去90天内机构目标均价为23.65。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共5家,其中持有数量最多的公募基金为安信医药健康股票A。安信医药健康股票A目前规模为19.52亿元,最新净值0.8884,较上一交易日下跌2.49%,近一年下跌27.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051615269f0935b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051615269f0935b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0239","BK0201","BK0012","600521","BK0185","BK0070","BK0188"],"gpt_icon":0},{"id":"2449232400","title":"7月5日华海药业涨停分析:创新药,化学原料药,新冠药物概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449232400","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449232400?lang=zh_cn&edition=full","pubTime":"2024-07-05 15:12","pubTimestamp":1720163577,"startTime":"0","endTime":"0","summary":"证券之星消息,华海药业7月5日涨停收盘,收盘价17.79元。该股于13点56分涨停,未打开涨停,截止收盘封单资金为4070.17万元,占其流通市值0.16%。7月5日的资金流向数据方面,主力资金净流入311.86万元,占总成交额0.44%,游资资金净流出1040.78万元,占总成交额1.48%,散户资金净流入728.92万元,占总成交额1.03%。近5日资金流向一览见下表:该股为创新药,化学原料药,新冠药物概念热股,当日创新药概念上涨4.46%,化学原料药概念上涨3.93%,新冠药物概念上涨3.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051514139f08c8db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407051514139f08c8db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0012","BK0070","BK0185","BK0201","BK0239","600521","159992","BK0188","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2003-03-04","address":"浙江省台州市临海市汛桥","stockEarnings":[{"period":"1week","weight":-0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":0.1765},{"period":"6month","weight":0.3842},{"period":"1year","weight":-0.0147},{"period":"ytd","weight":0.2191}],"companyName":"浙江华海药业股份有限公司","boardCode":"AI0027","perCapita":"20284股","boardName":"医药制造业","registeredCapital":"146675万元","compareEarnings":[{"period":"1week","weight":0.0023},{"period":"1month","weight":-0.0175},{"period":"3month","weight":-0.0288},{"period":"6month","weight":0.0511},{"period":"1year","weight":-0.0693},{"period":"ytd","weight":0.0007}],"survey":" 浙江华海药业股份有限公司主营业务为多剂型的仿制药、生物药、创新药及特色原料药的研发、生产和销售。公司的主要产品有心血管类、精神障碍类、神经系统类、抗感染类等为主导的产品系列。2023年4月,公司荣获“全国五一劳动奖状”和“浙江省五一劳动奖状”,同月,公司被浙江省药品检查中心认定为浙江省职业检查“尖兵领航”工程实训基地;2023年6月,公司入选米内网颁发的2022年度中国化药企业百强等。","serverTime":1721323443978,"listedPrice":15.55,"stockholders":"72310人(较上一季度减少1.88%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华海药业(600521)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华海药业(600521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华海药业,600521,华海药业股票,华海药业股票老虎,华海药业股票老虎国际,华海药业行情,华海药业股票行情,华海药业股价,华海药业股市,华海药业股票价格,华海药业股票交易,华海药业股票购买,华海药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华海药业(600521)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华海药业(600521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}